Immediate Impact
59 standout
Citing Papers
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Silvia Antolín being referenced
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study
2018
Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Silvia Antolín | 249 | 192 | 73 | 170 | 54 | 433 | |
| Shin Takayama | 232 | 140 | 104 | 160 | 35 | 470 | |
| Erika Matos | 202 | 193 | 70 | 102 | 27 | 391 | |
| Mai Tomiguchi | 143 | 269 | 80 | 274 | 24 | 481 | |
| Raquel Andrés | 151 | 145 | 110 | 160 | 30 | 437 | |
| Anna Badowska-Kozakiewicz | 223 | 130 | 83 | 152 | 65 | 460 | |
| Eirini Papadopoulou | 207 | 177 | 139 | 205 | 42 | 509 | |
| Jennifer Kane | 183 | 182 | 40 | 150 | 25 | 466 | |
| Xiaoyi Zhang | 224 | 89 | 62 | 154 | 37 | 464 | |
| Yolanda Jerez | 283 | 96 | 80 | 116 | 30 | 407 | |
| Byung Kyun Ko | 134 | 118 | 68 | 116 | 33 | 410 |
All Works
Login with ORCID to disown or claim papers
Loading papers...